Total Payments
$52,927
2023 Payments
$20.81
Companies
6
Transactions
9
Medicare Patients
3,564
Medicare Billing
$145,462
Payment Breakdown by Category
Research$52,575 (99.3%)
Food & Beverage$352.25 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $52,575 | 4 | 99.3% |
| Food and Beverage | $352.25 | 5 | 0.7% |
Payments by Type
Research
$52,575
4 transactions
General
$352.25
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Adare Pharmaceuticals, Inc. | $52,575 | 4 | $0 (2020) |
| Ipsen Biopharmaceuticals, Inc | $123.64 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $107.92 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $75.78 | 1 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $24.10 | 1 | $0 (2018) |
| Pharmacyclics LLC, An AbbVie Company | $20.81 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $20.81 | 1 | Pharmacyclics LLC, An AbbVie Company ($20.81) |
| 2020 | $21,525 | 2 | Adare Pharmaceuticals, Inc. ($21,525) |
| 2019 | $31,282 | 4 | Adare Pharmaceuticals, Inc. ($31,050) |
| 2018 | $24.10 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($24.10) |
| 2017 | $75.78 | 1 | AstraZeneca Pharmaceuticals LP ($75.78) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/09/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2020 | Adare Pharmaceuticals, Inc. | — | — | Cash or cash equivalent | $20,325.00 | Research |
| Study: Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE) | ||||||
| 08/05/2020 | Adare Pharmaceuticals, Inc. | — | — | Cash or cash equivalent | $1,200.00 | Research |
| Study: Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE) | ||||||
| 12/10/2019 | Adare Pharmaceuticals, Inc. | — | — | Cash or cash equivalent | $1,050.00 | Research |
| Study: SP-1011-002 | ||||||
| 10/25/2019 | Adare Pharmaceuticals, Inc. | — | — | Cash or cash equivalent | $30,000.00 | Research |
| Study: SP-1011-002 | ||||||
| 08/13/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $107.92 | General |
| Category: ONCOLOGY | ||||||
| 02/27/2019 | Ipsen Biopharmaceuticals, Inc | ONIVYDE (Drug) | Food and Beverage | In-kind items and services | $123.64 | General |
| Category: Oncology | ||||||
| 02/13/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2017 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $75.78 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| SP-1011-002 | Adare Pharmaceuticals, Inc. | $31,050 | 2 |
| Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE) | Adare Pharmaceuticals, Inc. | $21,525 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 824 | 1,164 | $201,208 | $30,794 |
| 2022 | 18 | 944 | 1,436 | $202,093 | $36,033 |
| 2021 | 17 | 852 | 1,195 | $202,585 | $30,735 |
| 2020 | 16 | 944 | 1,505 | $297,632 | $47,900 |
Total Patients
3,564
Total Services
5,300
Medicare Billing
$145,462
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 239 | 338 | $88,222 | $9,426 | 10.7% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 58 | 209 | $27,578 | $4,554 | 16.5% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2023 | 60 | 80 | $15,200 | $4,053 | 26.7% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 30 | 35 | $13,825 | $2,238 | 16.2% |
| 88108 | Cell examination of specimen, concentration technique | Facility | 2023 | 114 | 131 | $16,118 | $2,214 | 13.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 72 | 73 | $9,075 | $1,950 | 21.5% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 37 | 40 | $5,600 | $1,288 | 23.0% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2023 | 15 | 26 | $6,084 | $1,260 | 20.7% |
| 86077 | Blood bank physician services for cross match and/or evaluation and written report | Facility | 2023 | 22 | 25 | $1,225 | $961.25 | 78.5% |
| 88172 | Evaluation of fine needle aspirate | Facility | 2023 | 22 | 26 | $3,380 | $713.33 | 21.1% |
| 85390 | Coagulation function screening test with interpretation and report | Facility | 2023 | 36 | 40 | $760.00 | $596.39 | 78.5% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2023 | 12 | 25 | $1,500 | $511.87 | 34.1% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 42 | 47 | $9,024 | $400.26 | 4.4% |
| 84166 | Protein measurement, body fluid | Facility | 2023 | 20 | 20 | $540.00 | $349.40 | 64.7% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 14 | 18 | $1,062 | $172.83 | 16.3% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Facility | 2023 | 31 | 31 | $2,015 | $105.04 | 5.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 234 | 366 | $95,485 | $10,997 | 11.5% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 39 | 52 | $20,540 | $3,474 | 16.9% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2022 | 48 | 61 | $11,590 | $3,431 | 29.6% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 47 | 149 | $19,817 | $3,392 | 17.1% |
| 85576 | Platelet aggregation function test | Facility | 2022 | 50 | 171 | $3,249 | $2,532 | 77.9% |
| 88108 | Cell examination of specimen, concentration technique | Facility | 2022 | 100 | 120 | $14,760 | $2,155 | 14.6% |
| 84166 | Protein measurement, body fluid | Facility | 2022 | 95 | 101 | $2,727 | $1,862 | 68.3% |
| 86077 | Blood bank physician services for cross match and/or evaluation and written report | Facility | 2022 | 38 | 46 | $2,254 | $1,768 | 78.4% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 56 | 61 | $7,625 | $1,717 | 22.5% |
About Dr. Assad Saad, MD
Dr. Assad Saad, MD is a Cytopathology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457383705.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Assad Saad, MD has received a total of $52,927 in payments from pharmaceutical and medical device companies, with $20.81 received in 2023. These payments were reported across 9 transactions from 6 companies. The most common payment nature is "" ($52,575).
As a Medicare-enrolled provider, Saad has provided services to 3,564 Medicare beneficiaries, totaling 5,300 services with total Medicare billing of $145,462. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Cytopathology
- Other Specialties Anatomic Pathology & Clinical Pathology
- Location Dallas, TX
- Active Since 07/07/2006
- Last Updated 12/17/2007
- Taxonomy Code 207ZC0500X
- Entity Type Individual
- NPI Number 1457383705
Products in Payments
- ONIVYDE (Drug) $123.64
- KEYTRUDA (Biological) $107.92
- TAGRISSO (Drug) $75.78
- XIFAXAN (Drug) $24.10
- IMBRUVICA (Drug) $20.81
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cytopathology Doctors in Dallas
Luis De Las Casas, Md, MD
Cytopathology — Payments: $8,400
Cytopathology $8,400
Dr. Henry Chen, M.d, M.D
Cytopathology — Payments: $579.25
Cytopathology $579.25
Alexandra Gillespie, Md, MD
Cytopathology — Payments: $261.06
Cytopathology $261.06
Sunati Sahoo, Md, MD
Cytopathology — Payments: $64.87
Cytopathology $64.87
Aviva Hopkovitz, Md, MD
Cytopathology — Payments: $63.89
Cytopathology $63.89
Dale Odell, Md, MD
Cytopathology — Payments: $48.18
Cytopathology $48.18